| 标题 |
1005P MET testing and treatment (tx) sequencing after progression of disease (PD) on first-line (1L) osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and acquired MET overexpression and/or amplification (OverExp/Amp): Final analysis of a global real-world (rw) study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:J. Rotow; U. Malapelle; D. Cuadras; N. Lara; N. Caro; et al 出版日期:2025-12-23 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)